Published in HIV Med on December 20, 2008
Relationship between alcohol use categories and noninvasive markers of advanced hepatic fibrosis in HIV-infected, chronic hepatitis C virus-infected, and uninfected patients. Clin Infect Dis (2014) 2.24
HIV mono-infection is associated with FIB-4 - A noninvasive index of liver fibrosis - in women. Clin Infect Dis (2011) 1.37
Liver disease in the HIV-infected individual. Clin Gastroenterol Hepatol (2010) 1.33
Management of patients coinfected with HCV and HIV: a close look at the role for direct-acting antivirals. Gastroenterology (2012) 1.31
Focus on the liver: alcohol use, highly active antiretroviral therapy, and liver disease in HIV-infected patients. Alcohol Res Health (2010) 1.13
Alcohol Consumption, Progression of Disease and Other Comorbidities, and Responses to Antiretroviral Medication in People Living with HIV. AIDS Res Treat (2012) 0.94
Interleukin-6 is associated with noninvasive markers of liver fibrosis in HIV-infected patients with alcohol problems. AIDS Res Hum Retroviruses (2013) 0.92
Unhealthy alcohol use, HIV infection and risk of liver fibrosis in drug users with hepatitis C. PLoS One (2012) 0.88
Noncommunicable diseases in HIV infection in low- and middle-income countries: gastrointestinal, hepatic, and nutritional aspects. J Acquir Immune Defic Syndr (2014) 0.87
Alcohol use disorder and its impact on chronic hepatitis C virus and human immunodeficiency virus infections. World J Hepatol (2016) 0.85
Poorly Controlled HIV Infection: An Independent Risk Factor for Liver Fibrosis. J Acquir Immune Defic Syndr (2016) 0.84
Impact of lifetime alcohol use on liver fibrosis in a population of HIV-infected patients with and without hepatitis C coinfection. Alcohol Clin Exp Res (2013) 0.84
Risky alcohol use and serum aminotransferase levels in HIV-infected adults with and without hepatitis C. J Stud Alcohol Drugs (2013) 0.81
Direct and Indirect Effects of Heavy Alcohol Use on Clinical Outcomes in a Longitudinal Study of HIV Patients on ART. AIDS Behav (2016) 0.80
Aspartate aminotransferase to platelet ratio index (APRI) score is inappropriate for assessment of liver fibrosis in HIV-infected patients with hazardous drinking. HIV Med (2009) 0.78
Liver Function Tests Abnormalities and Hepatitis B Virus & Hepatitis C Virus Co-infection in Human Immunodeficiency Virus (HIV)-infected Patients in India. J Clin Exp Hepatol (2016) 0.75
Profile and prevalence of HBV among HIV affected individuals attending the largest public HIV care center in India. Virusdisease (2016) 0.75
A cross-sectional study of liver function tests in HIV-infected persons in Western India. Med J Armed Forces India (2017) 0.75
Actual causes of death in the United States, 2000. JAMA (2004) 44.38
A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology (2003) 16.40
Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial. JAMA (2006) 13.15
Diagnosis, management, and treatment of hepatitis C. Hepatology (2004) 11.62
Liver biopsy. N Engl J Med (2001) 9.91
Brief interventions for alcohol problems: a meta-analytic review of controlled investigations in treatment-seeking and non-treatment-seeking populations. Addiction (2002) 9.47
Liver-related deaths in persons infected with the human immunodeficiency virus: the D:A:D study. Arch Intern Med (2006) 9.21
The natural history of hepatitis C virus infection: host, viral, and environmental factors. JAMA (2000) 7.65
HIV-1, hepatitis B virus, and risk of liver-related mortality in the Multicenter Cohort Study (MACS). Lancet (2002) 5.60
Impact of active drug use on antiretroviral therapy adherence and viral suppression in HIV-infected drug users. J Gen Intern Med (2002) 5.30
The epidemiology of nonalcoholic fatty liver disease in adults. J Clin Gastroenterol (2006) 4.52
Hepatitis B and HIV: prevalence, AIDS progression, response to highly active antiretroviral therapy and increased mortality in the EuroSIDA cohort. AIDS (2005) 4.40
The prevalence of alcohol consumption and heavy drinking among people with HIV in the United States: results from the HIV Cost and Services Utilization Study. J Stud Alcohol (2002) 3.71
Understanding the clinical and economic outcomes of HIV therapy: the Johns Hopkins HIV clinical practice cohort. J Acquir Immune Defic Syndr Hum Retrovirol (1998) 3.69
Longitudinal assessment of the effects of drug and alcohol abuse on HIV-1 treatment outcomes in an urban clinic. AIDS (2002) 3.45
Alcohol consumption and antiretroviral adherence among HIV-infected persons with alcohol problems. Alcohol Clin Exp Res (2004) 3.24
A temporal and dose-response association between alcohol consumption and medication adherence among veterans in care. Alcohol Clin Exp Res (2005) 3.21
Liver disease as a major cause of death among HIV infected patients: role of hepatitis C and B viruses and alcohol. J Hepatol (2005) 3.18
Medical disease and alcohol use among veterans with human immunodeficiency infection: A comparison of disease measurement strategies. Med Care (2006) 2.82
Problem drinking and medication adherence among persons with HIV infection. J Gen Intern Med (2001) 2.81
Hazardous alcohol use: a risk factor for non-adherence and lack of suppression in HIV infection. J Acquir Immune Defic Syndr (2006) 2.78
Prediction of hepatic fibrosis in HIV/HCV co-infected patients using serum fibrosis markers: the SHASTA index. J Hepatol (2005) 2.64
Gender differences in factors associated with adherence to antiretroviral therapy. J Gen Intern Med (2004) 2.37
Slower fibrosis progression in HIV/HCV-coinfected patients with successful HIV suppression using antiretroviral therapy. J Hepatol (2005) 2.27
APRI: an easy and validated predictor of hepatic fibrosis in chronic hepatitis C. J Clin Gastroenterol (2006) 2.27
How harmful is hazardous alcohol use and abuse in HIV infection: do health care providers know who is at risk? J Acquir Immune Defic Syndr (2003) 2.14
HIV infection does not affect the performance of noninvasive markers of fibrosis for the diagnosis of hepatitis C virus-related liver disease. J Acquir Immune Defic Syndr (2005) 2.13
Comparison and validation of simple noninvasive tests for prediction of fibrosis in chronic hepatitis C. Hepatology (2005) 2.00
The role of laparoscopy in the diagnosis of cirrhosis. Gastrointest Endosc (1996) 1.89
Hepatitis C virus infection as an opportunistic disease in persons infected with human immunodeficiency virus. Clin Infect Dis (2000) 1.87
The influence of human immunodeficiency virus coinfection on chronic hepatitis C in injection drug users: a long-term retrospective cohort study. Hepatology (2001) 1.87
Limited effectiveness of antiviral treatment for hepatitis C in an urban HIV clinic. AIDS (2006) 1.82
Physician unawareness of serious substance abuse. Am J Drug Alcohol Abuse (1997) 1.54
A low-cost, sustainable intervention for drinking reduction in the HIV primary care setting. AIDS Care (2006) 1.41
Alcohol problems and health care services use in human immunodeficiency virus (HIV)-infected and HIV-uninfected veterans. Med Care (2006) 1.41
Alcohol use and incarceration adversely affect HIV-1 RNA suppression among injection drug users starting antiretroviral therapy. J Urban Health (2003) 1.38
Effect of alcohol use and highly active antiretroviral therapy on plasma levels of hepatitis C virus (HCV) in patients coinfected with HIV and HCV. Clin Infect Dis (2005) 1.32
Hepatitis C and alcohol: interactions, outcomes, and implications. J Clin Gastroenterol (2003) 1.30
Non-invasive models for predicting histology in patients with chronic hepatitis B. Liver Int (2006) 1.30
Validation of a simple model for predicting liver fibrosis in HIV/hepatitis C virus-coinfected patients. HIV Med (2005) 1.22
Aspartate aminotransferase to platelet ratio index in patients with alcoholic liver fibrosis. Am J Gastroenterol (2006) 1.18
Hematologic complications of HIV infection. AIDS Rev (2006) 1.12
Validation and comparison of indexes for fibrosis and cirrhosis prediction in chronic hepatitis C patients: proposal for a pragmatic approach classification without liver biopsies. J Viral Hepat (2006) 1.07
Excess alcohol consumption is common in patients with cytopenia: studies in blood and bone marrow cells. Alcohol Clin Exp Res (2004) 1.00
Assessment of liver fibrosis progression in patients with chronic hepatitis C and normal alanine aminotransferase values: the role of AST to the platelet ratio index. Clin Biochem (2006) 0.92
Comparison of the combined marker GGT-CDT and the conventional laboratory markers of alcohol abuse in heavy drinkers, moderate drinkers and abstainers. Alcohol Alcohol (2006) 0.88
The utility of aspartate aminotransferase/platelet ratio index in HIV/hepatitis C-co-infected patients. AIDS (2007) 0.80
Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia. N Engl J Med (1995) 13.59
Clinical response to aminoglycoside therapy: importance of the ratio of peak concentration to minimal inhibitory concentration. J Infect Dis (1987) 5.63
Highly active antiretroviral therapy in a large urban clinic: risk factors for virologic failure and adverse drug reactions. Ann Intern Med (1999) 5.05
Prevalence of type 2 diabetes mellitus among persons with hepatitis C virus infection in the United States. Ann Intern Med (2000) 4.83
Self-reported antiretroviral therapy in injection drug users. JAMA (1998) 4.75
Clostridium difficile colitis: an efficient clinical approach to diagnosis. Ann Intern Med (1995) 4.42
Detrimental effects of continued illicit drug use on the treatment of HIV-1 infection. J Acquir Immune Defic Syndr (2001) 3.67
Incidence and natural history of cytomegalovirus disease in patients with advanced human immunodeficiency virus disease treated with zidovudine. The Zidovudine Epidemiology Study Group. J Infect Dis (1992) 3.61
Race, sex, drug use, and progression of human immunodeficiency virus disease. N Engl J Med (1995) 3.44
Hydroxyurea: effects on hemoglobin F production in patients with sickle cell anemia. Blood (1992) 3.09
Net costs from three perspectives of using low versus high osmolality contrast medium in diagnostic angiocardiography. J Am Coll Cardiol (1993) 2.72
Knowledge, attitudes, and reported practices of medical students and house staff regarding the diagnosis and treatment of alcoholism. JAMA (1989) 2.56
Association of aminoglycoside plasma levels with therapeutic outcome in gram-negative pneumonia. Am J Med (1984) 2.54
Potential factors affecting adherence with HIV therapy. AIDS (1997) 2.44
The association of aminoglycoside plasma levels with mortality in patients with gram-negative bacteremia. J Infect Dis (1984) 2.44
Characteristics, diagnosis, and treatment of alcoholism in elderly patients. J Am Geriatr Soc (1989) 2.43
Association of initial CD4 cell count and viral load with response to highly active antiretroviral therapy. JAMA (2000) 2.25
Moderate alcohol consumption and coronary artery disease. A review. Medicine (Baltimore) (1986) 2.22
A randomized, controlled trial of interventions to improve adherence to isoniazid therapy to prevent tuberculosis in injection drug users. Am J Med (2001) 2.15
Racial and ethnic differences in outcome in zidovudine-treated patients with advanced HIV disease. Zidovudine Epidemiology Study Group. JAMA (1991) 2.08
Clinical spectrum of herpes zoster in adults infected with human immunodeficiency virus. Clin Infect Dis (1995) 2.01
31P NMR studies of intracellular free Mg2+ in intact frog skeletal muscle. J Biol Chem (1980) 2.01
NMR studies of intracellular metal ions in intact cells and tissues. Annu Rev Biophys Bioeng (1984) 1.97
Cryptosporidiosis in patients with AIDS: correlates of disease and survival. Clin Infect Dis (1998) 1.97
Hydroxyurea and sickle cell anemia. Clinical utility of a myelosuppressive "switching" agent. The Multicenter Study of Hydroxyurea in Sickle Cell Anemia. Medicine (Baltimore) (1996) 1.90
Adherence to antiretroviral and pneumocystis prophylaxis in HIV disease. J Acquir Immune Defic Syndr Hum Retrovirol (1998) 1.89
Differences in HIV disease progression by injection drug use and by sex in the era of highly active antiretroviral therapy. AIDS (2001) 1.88
Prophylaxis for opportunistic infections in patients with HIV infection. Ann Intern Med (1994) 1.87
Estimating the future health burden of chronic hepatitis C and human immunodeficiency virus infections in the United States. J Viral Hepat (2007) 1.86
Impact of opportunistic disease on survival in patients with HIV infection. AIDS (1998) 1.71
Alcohol abuse: comparison of two methods for assessing its prevalence and associated morbidity in hospitalized patients. Am J Med (1991) 1.66
Predictors of outpatient treatment retention: patient versus substance use characteristics. Drug Alcohol Depend (2001) 1.60
HIV-1 RNA, CD4 T-lymphocytes, and clinical response to highly active antiretroviral therapy. AIDS (2001) 1.60
The effect of adjunctive corticosteroids for the treatment of Pneumocystis carinii pneumonia on mortality and subsequent complications. Chest (1998) 1.58
Risk factors for fluconazole-resistant candidiasis in human immunodeficiency virus-infected patients. J Infect Dis (1996) 1.58
Risk factors for nephrotoxicity in patients treated with aminoglycosides. Ann Intern Med (1984) 1.57
Implications for macrolide treatment in community-acquired pneumonia. Hopkins CAP Team. Chest (1998) 1.57
The impact of prophylaxis on outcome and resource utilization in Pneumocystis carinii pneumonia. Chest (1995) 1.53
Risk factors for the development of auditory toxicity in patients receiving aminoglycosides. J Infect Dis (1984) 1.52
Protease inhibitor exposure and increased risk of cardiovascular disease in HIV-infected patients. HIV Med (2005) 1.49
The impact of illicit drug use and substance abuse treatment on adherence to HAART. AIDS Care (2007) 1.48
Prevention of opportunistic infections in the era of improved antiretroviral therapy. J Acquir Immune Defic Syndr Hum Retrovirol (1997) 1.46
Vancomycin-resistant and vancomycin-susceptible enterococcal bacteremia: comparison of clinical features and outcomes. Clin Infect Dis (1998) 1.45
Lack of association between acyclovir use and survival in patients with advanced human immunodeficiency virus disease treated with zidovudine. Zidovudine Epidemiology Study Group. J Infect Dis (1995) 1.45
The effect of acute infectious illnesses on plasma human immunodeficiency virus (HIV) type 1 load and the expression of serologic markers of immune activation among HIV-infected adults. J Infect Dis (1998) 1.40
Safety and cost effectiveness of high-osmolality as compared with low-osmolality contrast material in patients undergoing cardiac angiography. N Engl J Med (1992) 1.40
Infection due to fluconazole-resistant Candida in patients with AIDS: prevalence and microbiology. Clin Infect Dis (1997) 1.38
Incidence and natural history of Mycobacterium avium-complex infections in patients with advanced human immunodeficiency virus disease treated with zidovudine. The Zidovudine Epidemiology Study Group. Am Rev Respir Dis (1992) 1.38
The new paradigm of hepatitis C therapy: integration of oral therapies into best practices. J Viral Hepat (2013) 1.37
Hospitalization rates in an urban cohort after the introduction of highly active antiretroviral therapy. J Acquir Immune Defic Syndr (2001) 1.36
Effect of antiretroviral therapy on the incidence of bacterial pneumonia in patients with advanced HIV infection. Am J Respir Crit Care Med (2000) 1.35
Costs of HIV medical care in the era of highly active antiretroviral therapy. AIDS (1999) 1.33
Design of the multicenter study of hydroxyurea in sickle cell anemia. Investigators of the Multicenter Study of Hydroxyurea. Control Clin Trials (1995) 1.32
Delayed hatching of salamander eggs in response to enhanced larval predation risk. Am Nat (1993) 1.31
Community-acquired pneumonia: impact of immune status. Am J Respir Crit Care Med (1995) 1.29
Stimulation of Na:H exchange by insulin. Biophys J (1981) 1.28
Zidovudine use but not weight-based ribavirin dosing impacts anaemia during HCV treatment in HIV-infected persons. J Viral Hepat (2006) 1.26
Bacteroides fragilis toxin exhibits polar activity on monolayers of human intestinal epithelial cells (T84 cells) in vitro. Infect Immun (1997) 1.26
Effects of insulin upon ion transport. Biochim Biophys Acta (1983) 1.25
Hepatomegaly and steatosis in HIV-infected patients receiving nucleoside analog antiretroviral therapy. Am J Gastroenterol (1995) 1.24
Emergency department utilization among HIV-infected patients in a multisite multistate study. HIV Med (2009) 1.15
Social integration and black intraracial variation in blood pressure. Ethn Dis (1991) 1.15
Disulfiram treatment of alcoholism. Am J Med (1990) 1.15
Lessons learned from the design and implementation of myocardial infarction adjudication tailored for HIV clinical cohorts. Am J Epidemiol (2014) 1.14
A clinicopathologic analysis of AIDS-related cryptosporidiosis. AIDS (1998) 1.14
Intracellular pH mediates action of insulin on glycolysis in frog skeletal muscle. Am J Physiol (1982) 1.13
Effect of insulin upon the sodium pump in frog skeletal muscle. J Physiol (1973) 1.13
Effects of an incentive and education program on return rates for PPD test reading in patients with HIV infection. J Acquir Immune Defic Syndr Hum Retrovirol (1996) 1.11
Cryptosporidiosis in northeastern Brazilian children: association with increased diarrhea morbidity. J Infect Dis (1998) 1.09
Nitric oxide successfully used to treat acute chest syndrome of sickle cell disease in a young adolescent. Crit Care Med (1999) 1.07
Effect of insulin upon membrane-bound (Na+ + K+)-ATPase extracted from frog skeletal muscle. J Physiol (1975) 1.07
Infectious arthritis due to Propionibacterium acnes in a prosthetic joint. Clin Infect Dis (1994) 1.06
Hepatitis C treatment among racial and ethnic groups in the IDEAL trial. J Viral Hepat (2010) 1.06
Interleukin 28B polymorphisms are the only common genetic variants associated with low-density lipoprotein cholesterol (LDL-C) in genotype-1 chronic hepatitis C and determine the association between LDL-C and treatment response. J Viral Hepat (2012) 1.04
The incidence of and risk factors for MRSA bacteraemia in an HIV-infected cohort in the HAART era. HIV Med (2008) 1.03
A model for predicting nephrotoxicity in patients treated with aminoglycosides. J Infect Dis (1986) 1.01
Association of a polymorphism in the indoleamine- 2,3-dioxygenase gene and interferon-α-induced depression in patients with chronic hepatitis C. Mol Psychiatry (2011) 1.01
Functional status of persons with HIV infection in an ambulatory setting. J Acquir Immune Defic Syndr (1994) 1.00
Substance abuse-related admissions to adult intensive care. Chest (1993) 1.00
Body shape and composition in HIV-infected women: an urban cohort. HIV Med (2005) 1.00
Virological outcomes and treatment algorithms utilisation in observational study of patients with chronic hepatitis C treated with boceprevir or telaprevir. Aliment Pharmacol Ther (2015) 0.97
Elevation of intracellular pH by insulin in frog skeletal muscle. Biochem Biophys Res Commun (1979) 0.97
Nonlinear modeling of alcohol consumption for analysis of beverage type effects and beverage preference effects. Am J Epidemiol (1992) 0.97
Risk factors for pneumococcal disease in human immunodeficiency virus-infected patients. J Infect Dis (1996) 0.96
Restimulation of antibody synthesis by antigen in cultures of lymphocytes. Nature (1968) 0.96
Letter: Personnel monitoring in diagnostic radiology. Br J Radiol (1973) 0.96
Synthesis of antibody by lymphocytes restimulated in vitro with antigen. J Reticuloendothel Soc (1971) 0.95
Use of glycated hemoglobin and microalbuminuria in the monitoring of diabetes mellitus. Evid Rep Technol Assess (Summ) (2003) 0.94
Transplantation of autoimmune potential. II. Glomerulonephritis in lethally irradiated DBA/2 recipients of NZB bone marrow cells. Transplantation (1975) 0.94
Increasing incidence of avascular necrosis of the hip in HIV-infected patients. J Acquir Immune Defic Syndr (2001) 0.93
Studies of risk factors for aminoglycoside nephrotoxicity. Am J Kidney Dis (1986) 0.93
Suppression of established Friend virus leukemia by statolon. I. Demonstration of a latent infection in clinically normal mice. J Virol (1969) 0.92
Mechanism of insulin action on resting membrane potential of frog skeletal muscle. Am J Physiol (1979) 0.92
Low gene flow but high genetic diversity in the threatened Mallorcan midwife toad Alytes muletensis. Mol Ecol (2005) 0.92
Prevalence of type 2 diabetes mellitus among persons with hepatitis C virus infection in the United States. Hepatology (2001) 0.91
A possible mechanism for concentrating sodium and potassium in the cell nucleus. Biophys J (1976) 0.91
Herpes zoster in patients with advanced human immunodeficiency virus infection treated with zidovudine. Zidovudine Epidemiology Study Group. J Infect Dis (1993) 0.91